Adinarayana Kunamneni

Title: Adinarayana Kunamneni: Innovator in Pain Relief and Filovirus Detection

Introduction

Adinarayana Kunamneni is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the fields of pain relief and infectious disease detection through his innovative patents. With a total of 3 patents, his work focuses on developing compositions that utilize antibodies for therapeutic applications.

Latest Patents

One of Kunamneni's latest patents is titled "Compositions comprising antibodies or antibody fragments which bind the P2X4 receptor." This composition is designed for treating pain and includes an antibody or antibody fragment that specifically binds to a receptor involved in pain, particularly the P2X4 receptor. The composition may also include a detectable marker, such as a fluorescent tag, and is intended for use in treating both acute and chronic pain. The methods outlined in this patent suggest administering the composition to subjects to alleviate pain-related behaviors in various models.

Another significant patent is "Filovirus antibodies and methods." This patent describes an antibody that binds to a filovirus glycoprotein, which includes specific complementarity determining regions (CDRs). The antibody can be utilized to detect filovirus in biological samples and may be formulated into a pharmaceutical composition for subjects at risk of filovirus infection.

Career Highlights

Adinarayana Kunamneni has worked with prestigious institutions, including the University of New Mexico and Loyola University of Chicago. His research and innovations have contributed to advancements in medical science, particularly in the areas of pain management and infectious disease.

Collaborations

Throughout his career, Kunamneni has collaborated with notable colleagues, including Ravi Durvasula and Karin Westlund High. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

Adinarayana Kunamneni is a distinguished inventor whose work in antibody-based compositions has the potential to revolutionize pain treatment and filovirus detection. His contributions to science and medicine continue to pave the way for innovative solutions in healthcare.